E Björkenstam1, C Björkenstam2, B Jablonska3, K Kosidou3. 1. Division of Social Medicine,Department of Public Health Sciences,Karolinska Institutet,Stockholm,Sweden. 2. Department of Epidemiology,Fielding School of Public Health, University of California Los Angeles,Los Angeles,USA. 3. Division Public Health Epidemiology,Department of Public Health Sciences,Karolinska Institutet,Stockholm,Sweden.
Abstract
BACKGROUND: Though childhood adversity (CA) has been associated with the risk of attention deficit/hyperactivity disorder (ADHD), little is known about the effect of cumulative CAs and whether there are clusters of CAs that are more closely related with ADHD. METHODS: We used a Swedish cohort of 543 650 individuals born 1987-1991. Register-based CAs included familial death, substantial parental substance abuse and psychiatric disorder, substantial parental criminality, parental separation, household public assistance recipiency, and residential instability. Individuals were followed from year 2006 when they were 15-19 years of age, for treated ADHD, defined as a registered ICD diagnosis and/or prescription of medications to treat ADHD. Logistic regression analysis was used to calculate odds ratios (OR) with 95% confidence intervals (CI). Latent Class Analyses (LCA) were used to identify clusters based on the different CAs. RESULTS: All CAs increased the odds of ADHD in late adolescence and early adulthood; ORs ranged from 1.6 (95% CI 1.5-1.8) for familial death to 2.7 (95% CI 2.6-2.9) for household public assistance. We found a dose-response relationship between cumulative CA and ADHD; individuals with 4+ CAs had a markedly increased risk for ADHD (OR 5.5, 95% CI 5.0-6.0). LCA analyses revealed six distinct classes of CA associated with ADHD, of which 'exposure to most adversities' entailed highest risk. CONCLUSION: CA is a strong risk factor for ADHD, particularly when accumulated. Early and efficient detection of CA is of importance for interventions targeted to improve long-term mental health outcomes among disadvantaged children.
BACKGROUND: Though childhood adversity (CA) has been associated with the risk of attention deficit/hyperactivity disorder (ADHD), little is known about the effect of cumulative CAs and whether there are clusters of CAs that are more closely related with ADHD. METHODS: We used a Swedish cohort of 543 650 individuals born 1987-1991. Register-based CAs included familial death, substantial parental substance abuse and psychiatric disorder, substantial parental criminality, parental separation, household public assistance recipiency, and residential instability. Individuals were followed from year 2006 when they were 15-19 years of age, for treated ADHD, defined as a registered ICD diagnosis and/or prescription of medications to treat ADHD. Logistic regression analysis was used to calculate odds ratios (OR) with 95% confidence intervals (CI). Latent Class Analyses (LCA) were used to identify clusters based on the different CAs. RESULTS: All CAs increased the odds of ADHD in late adolescence and early adulthood; ORs ranged from 1.6 (95% CI 1.5-1.8) for familial death to 2.7 (95% CI 2.6-2.9) for household public assistance. We found a dose-response relationship between cumulative CA and ADHD; individuals with 4+ CAs had a markedly increased risk for ADHD (OR 5.5, 95% CI 5.0-6.0). LCA analyses revealed six distinct classes of CA associated with ADHD, of which 'exposure to most adversities' entailed highest risk. CONCLUSION: CA is a strong risk factor for ADHD, particularly when accumulated. Early and efficient detection of CA is of importance for interventions targeted to improve long-term mental health outcomes among disadvantaged children.
Authors: Stephen V Faraone; Tobias Banaschewski; David Coghill; Yi Zheng; Joseph Biederman; Mark A Bellgrove; Jeffrey H Newcorn; Martin Gignac; Nouf M Al Saud; Iris Manor; Luis Augusto Rohde; Li Yang; Samuele Cortese; Doron Almagor; Mark A Stein; Turki H Albatti; Haya F Aljoudi; Mohammed M J Alqahtani; Philip Asherson; Lukoye Atwoli; Sven Bölte; Jan K Buitelaar; Cleo L Crunelle; David Daley; Søren Dalsgaard; Manfred Döpfner; Stacey Espinet; Michael Fitzgerald; Barbara Franke; Manfred Gerlach; Jan Haavik; Catharina A Hartman; Cynthia M Hartung; Stephen P Hinshaw; Pieter J Hoekstra; Chris Hollis; Scott H Kollins; J J Sandra Kooij; Jonna Kuntsi; Henrik Larsson; Tingyu Li; Jing Liu; Eugene Merzon; Gregory Mattingly; Paulo Mattos; Suzanne McCarthy; Amori Yee Mikami; Brooke S G Molina; Joel T Nigg; Diane Purper-Ouakil; Olayinka O Omigbodun; Guilherme V Polanczyk; Yehuda Pollak; Alison S Poulton; Ravi Philip Rajkumar; Andrew Reding; Andreas Reif; Katya Rubia; Julia Rucklidge; Marcel Romanos; J Antoni Ramos-Quiroga; Arnt Schellekens; Anouk Scheres; Renata Schoeman; Julie B Schweitzer; Henal Shah; Mary V Solanto; Edmund Sonuga-Barke; César Soutullo; Hans-Christoph Steinhausen; James M Swanson; Anita Thapar; Gail Tripp; Geurt van de Glind; Wim van den Brink; Saskia Van der Oord; Andre Venter; Benedetto Vitiello; Susanne Walitza; Yufeng Wang Journal: Neurosci Biobehav Rev Date: 2021-02-04 Impact factor: 9.052
Authors: Shareefa Dalvie; Adam X Maihofer; Jonathan R I Coleman; Bekh Bradley; Gerome Breen; Leslie A Brick; Chia-Yen Chen; Karmel W Choi; Laramie E Duncan; Guia Guffanti; Magali Haas; Supriya Harnal; Israel Liberzon; Nicole R Nugent; Allison C Provost; Kerry J Ressler; Katy Torres; Ananda B Amstadter; S Bryn Austin; Dewleen G Baker; Elizabeth A Bolger; Richard A Bryant; Joseph R Calabrese; Douglas L Delahanty; Lindsay A Farrer; Norah C Feeny; Janine D Flory; David Forbes; Sandro Galea; Aarti Gautam; Joel Gelernter; Rasha Hammamieh; Marti Jett; Angela G Junglen; Milissa L Kaufman; Ronald C Kessler; Alaptagin Khan; Henry R Kranzler; Lauren A M Lebois; Charles Marmar; Matig R Mavissakalian; Alexander McFarlane; Meaghan O' Donnell; Holly K Orcutt; Robert H Pietrzak; Victoria B Risbrough; Andrea L Roberts; Alex O Rothbaum; Peter Roy-Byrne; Ken Ruggiero; Antonia V Seligowski; Christina M Sheerin; Derrick Silove; Jordan W Smoller; Murray B Stein; Martin H Teicher; Robert J Ursano; Miranda Van Hooff; Sherry Winternitz; Jonathan D Wolff; Rachel Yehuda; Hongyu Zhao; Lori A Zoellner; Dan J Stein; Karestan C Koenen; Caroline M Nievergelt Journal: Transl Psychiatry Date: 2020-01-27 Impact factor: 6.222
Authors: Catharina A Hartman; Nanda Rommelse; Cees L van der Klugt; Rob B K Wanders; Marieke E Timmerman Journal: J Clin Med Date: 2019-11-01 Impact factor: 4.241
Authors: Nicholas James Spencer; Johnny Ludvigsson; Guannan Bai; Lise Gauvin; Susan A Clifford; Yara Abu Awad; Jeremy D Goldhaber-Fiebert; Wolfgang Markham; Åshild Faresjö; Pär Andersson White; Hein Raat; Pauline Jansen; Béatrice Nikiema; Fiona K Mensah; Jennifer J McGrath Journal: PLoS One Date: 2022-03-16 Impact factor: 3.240
Authors: Ting Li; Barbara Franke; Alejandro AriasVasquez; Nina Roth Mota Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2020-12-15 Impact factor: 3.568
Authors: Steffen Barra; Daniel Turner; Marcus Müller; Priscilla Gregorio Hertz; Petra Retz-Junginger; Oliver Tüscher; Michael Huss; Wolfgang Retz Journal: Eur Arch Psychiatry Clin Neurosci Date: 2020-08-11 Impact factor: 5.270